{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:10:34Z","timestamp":1738714234198,"version":"3.37.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Pharm Res"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1007\/bf02977680","type":"journal-article","created":{"date-parts":[[2008,11,28]],"date-time":"2008-11-28T15:48:03Z","timestamp":1227887283000},"page":"483-487","source":"Crossref","is-referenced-by-count":5,"title":["Pharmacokinetics of verapamil and its major metabolite, nor-verapamil from oral administration of verapamil in rabbits with hepatic failure induced by carbon tetrachloride"],"prefix":"10.1007","volume":"28","author":[{"given":"Jun Shik","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Pil","family":"Burm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02977680_CR1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-5347(24)06111-1","volume":"7","author":"M. Eichelbaum","year":"1979","unstructured":"Eichelbaum, M., Remberg, E. G., Schomerus, M., and Dengler, H. J., The metabolism of D, L(14C) verapamil in man.Drug Metab. Dispos., 7, 145\u2013148 (1979).","journal-title":"Drug Metab. Dispos."},{"key":"BF02977680_CR2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2125.1980.tb01800.x","volume":"10","author":"M. Eichelbaum","year":"1980","unstructured":"Eichelbaum, M., Albrecht, M., Kliems, G., Schafer, K., and Somogyi, A., Influence of mesocaval shunt or surgery on verapamil kinetics, bioavailability and response.Brit. J. Clin. Pharmacol., 10, 527\u2013529 (1980).","journal-title":"Brit. J. Clin. Pharmacol."},{"key":"BF02977680_CR3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2125.1984.tb02371.x","volume":"17","author":"M. Eichelbaum","year":"1984","unstructured":"Eichelbaum, M., Mikus, G., and Vogelgesang, B., Pharmacokinetics of (+)-, (-)-and (\u00b1)-verapamil after intravenous administration.Brit. J. Clin. Pharmacol., 17, 453\u2013458 (1984).","journal-title":"Brit. J. Clin. Pharmacol."},{"key":"BF02977680_CR4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev.pa.17.040177.001053","volume":"17","author":"A. Fleckenstein","year":"1977","unstructured":"Fleckenstein, A., Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle.Ann. Rev. Pharmacol. Toxicol., 17, 149\u2013166 (1977).","journal-title":"Ann. Rev. Pharmacol. Toxicol."},{"key":"BF02977680_CR5","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/clpt.1981.216","volume":"30","author":"S. B. Freedman","year":"1981","unstructured":"Freedman, S. B., Richmond, D. R., Ashley, J. J., and Kelly, D. T., Verapamil kinetics in normal subjects and patients with coronary artery spasm.Clin. Pharmacol. Ther., 30, 644\u2013652 (1981).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF02977680_CR6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/01.CIR.65.1.22","volume":"65","author":"B. A. Gould","year":"1982","unstructured":"Gould, B. A., Mann, S., Kieso, H., Bala Subramanian, V., and Raftery, E. B., The 24-hour ambulatory blood pressure profile with verapamil.Circulation, 65, 22\u201327 (1982).","journal-title":"Circulation"},{"key":"BF02977680_CR7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1067\/mcp.2000.109356","volume":"68","author":"M. E. Krecic-Shepard","year":"2000","unstructured":"Krecic-Shepard, M. E., Bamas, C. R., Slimko, J., and Schwartz, J. B., Faster clearance of sustained release verapamil in men versus women: Continuing observations on sex-specific differences after oral administration of verapamil.Clin. Pharmacol. Then, 68, 286\u2013292 (2000).","journal-title":"Clin. Pharmacol. Then"},{"key":"BF02977680_CR8","first-page":"351","volume":"87","author":"G. R. Lewis","year":"1978","unstructured":"Lewis, G. R., Morley, K. D., Lewis, B. M., and Bones, P. J., The treatment of hypertension with verapamil.NZ. Medical J., 87, 351\u2013354 (1978).","journal-title":"NZ. Medical J."},{"key":"BF02977680_CR9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0010-468X(83)90082-X","volume":"16","author":"M. L. Rocci","year":"1983","unstructured":"Rocci, M. L., and Jusko, W. J., LAGRAN program for area and moments in pharmacokinetic analysis.Computer Programs in Biomedicine, 16, 203\u2013209 (1983).","journal-title":"Computer Programs in Biomedicine"},{"key":"BF02977680_CR10","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/cvr\/10.5.605","volume":"10","author":"M. Schomerus","year":"1976","unstructured":"Schomerus, M., Spiegelhaider, B., Stieren, B., and Eichelbaum, M., Physiologic disposition of verapamil in man.Cardiovasc. Res., 10, 605\u2013612 (1976).","journal-title":"Cardiovasc. Res."},{"key":"BF02977680_CR11","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2125.1985.tb02678.x","volume":"19","author":"J. B. Schwartz","year":"1985","unstructured":"Schwartz, J. B., Abernethy, D. R., Taylor, A. A., and Mitchell, J. R., An investigation of the cause of accumulation of verapamil during regular dosing in patients.Brit. J. Clin. Pharmacol., 19, 512\u2013516 (1985).","journal-title":"Brit. J. Clin. Pharmacol."},{"key":"BF02977680_CR12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2125.1981.tb01854.x","volume":"12","author":"A. Somogyi","year":"1981","unstructured":"Somogyi, A., Albrecht, M., Kliems, G., Schafer, K., and Eichelbaum, M., Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosis.Brit. J. Clin. Pharmacol., 12, 51\u201360 (1981).","journal-title":"Brit. J. Clin. Pharmacol."},{"key":"BF02977680_CR13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/clpt.1981.5","volume":"29","author":"B. G. Woodcock","year":"1981","unstructured":"Woodcock, B. G., Rietbrock, I., Vohringer, H. F., and Rietbrock, N., Verapamil disposition in liver disease and intensive-care patients: Kinetics, clearance, and apparent blood flow relationships.Clin. Pharmacol. Ther., 29, 27\u201334 (1981).","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02977680.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02977680\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02977680","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T23:46:43Z","timestamp":1738712803000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02977680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["BF02977680"],"URL":"https:\/\/doi.org\/10.1007\/bf02977680","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"type":"print","value":"0253-6269"},{"type":"electronic","value":"1976-3786"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}